Literature DB >> 1280989

Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle.

D A Schuschke1, M W Reed, J T Saari, M D Olson, D M Ackermann, F N Miller.   

Abstract

The effect of dietary copper deficiency on tumour growth, neovascularisation and microvascular integrity was studied in the rat cremaster muscle. Male, weanling Sprague-Dawley rats were fed purified diets which were copper deficient (< 0.5 micrograms g-1 of diet) or copper adequate (5 micrograms g-1 of diet). Seven days after initiation of diets, a chondrosarcoma was implanted in the cremaster muscle of each rat. Five, 10 or 20 days after tumour implantation, rats were anesthetised and their cremasters prepared for observation by intravital microscopy. Intraarterial injection of fluorescein isothiocyanate-conjugated albumin and subsequent observation of fluorescence in the perivascular space indicated no difference in microvascular albumin leakage between the tumour vasculature of copper deficient and copper adequate rats. Neither tumour growth (assessed by wet weight), vascular density (assessed by light microscopy), nor any ultrastructural characteristics of the tumour or its vasculature (assessed by electron microscopy) were affected by copper deficiency. In view of findings by others which indicate changes in tumour characteristics with copper deficiency, we conclude that the copper dependency of tumour growth and vascularisation is a function of the type of tumour, the host tissue, or the conditions of copper depletion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280989      PMCID: PMC1978058          DOI: 10.1038/bjc.1992.410

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  The effects of copper deficiency on the pyridinium crosslinks of mature collagen in the rat skeleton and cardiovascular system.

Authors:  C Farquharson; A Duncan; S P Robins
Journal:  Proc Soc Exp Biol Med       Date:  1989-11

2.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

3.  Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea.

Authors:  A Parke; P Bhattacherjee; R M Palmer; N R Lazarus
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

4.  Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier.

Authors:  D Zagzag; S Brem; F Robert
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

5.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

6.  Tumor angiogenesis: a quantitative method for histologic grading.

Authors:  S Brem; R Cotran; J Folkman
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

7.  Microvascular responses in copper-deficient rats.

Authors:  D A Schuschke; J T Saari; D M Ackermann; F N Miller
Journal:  Am J Physiol       Date:  1989-11

8.  Heparin-copper biaffinity chromatography of fibroblast growth factors.

Authors:  Y Shing
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

9.  Role of prostaglandin E1 and copper in angiogenesis.

Authors:  M Ziche; J Jones; P M Gullino
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

10.  Differential macromolecular leakage from the vasculature of tumors.

Authors:  L S Heuser; F N Miller
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

View more
  1 in total

1.  Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration.

Authors:  Andrew Crowe; Connie Jackaman; Katie M Beddoes; Belinda Ricciardo; Delia J Nelson
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.